Neuraxpharm expands its business in Southeast Europe Acquisition of Brain Therapeutics with operations in Greece, Cyprus and the Balkan countries Dusseldorf and Barcelona, March 8th, 2022 - Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous.
DJ LogicBio Therapeutics Announces Early Clinical Trial Results Demonstrating First-Ever In Vivo Genome Editing in Children Arix Bioscience PLC (ARIX) LogicBio Therapeutics Announces Early Clinical
DJ LogicBio Therapeutics Announces Early Clinical Trial Results Demonstrating First-Ever In Vivo Genome Editing in Children Arix Bioscience PLC (ARIX) LogicBio Therapeutics Announces Early Clinical